Meningococcal Vaccine (Group A, C, Y & W-135)
Information about Meningococcal Vaccine (Group A, C, Y & W-135)
Meningococcal vaccine (group a, c, y & w-135) uses
Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
How meningococcal vaccine (group a, c, y & w-135) works
Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Common side effects of meningococcal vaccine (group a, c, y & w-135)
Dizziness, Headache, Injection site pain, Injection site redness, Injection site induration (hardening of a normally soft tissue or organ), Irritability, Sleepiness, General discomfort, Muscle pain, Nausea, Injection site itching, Swelling of lymph nodes
Available Medicine for Meningococcal Vaccine (Group A, C, Y & W-135)
Expert advice for Meningococcal Vaccine (Group A, C, Y & W-135)
- Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
- It is not recommended for use in infants and children under 9 months of age.
- It is usually given by injection into the muscle of the upper arm.
- Your doctor will advise you if and when you should receive a booster dose.
- Immunocompromised individuals or persons suffering from functional or anatomic asplenia (including sickle cell disease) should get it.
- People travelling to US & Europe, Hajj (as meningococcal meningitis is more prevalent there) are advised to get vaccinated with Meningococcal Vaccine (Group A, C, Y & W-135).
Frequently asked questions for Meningococcal Vaccine (Group A, C, Y & W-135)
Meningococcal Vaccine (Group A, C, Y & W-135)
Q. What is Meningococcal Vaccine (Group A, C, Y & W-135)?
Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Meningococcal Vaccine (Group A, C, Y & W-135) is approved for use in persons aged 2 months through 55 years.
Q. Who should not take Meningococcal Vaccine (Group A, C, Y & W-135)?
Meningococcal Vaccine (Group A, C, Y & W-135) should not be given to patients with known allergy to any other ingredients of this medicine, or any other similar medicines in the past. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. If you have had an allergic reaction to any medicine earlier, inform your doctor about it.
Q. Is a booster dose of Meningococcal Vaccine (Group A, C, Y & W-135) needed?
Yes, a single booster dose of Meningococcal Vaccine (Group A, C, Y & W-135) may be administered to individuals aged 15 through 55 years who may be at a continued risk of getting meningococcal disease, if at least 4 years have passed since a prior dose of it was given. If you have any doubts, consult your doctor.